Literature DB >> 11791576

Tandem mass spectrometric determination of the 4S/6S sulfation sequence in chondroitin sulfate oligosaccharides.

J Zaia1, J E McClellan, C E Costello.   

Abstract

Chondroitin sulfate (CS) is a glycosaminoglycan consisting of repeating uronic acid, N-acetylgalactosamine sulfate disaccharide units [-UroA(beta1,3)-GalNAcS(beta1,4)]n. Chondroitin sulfate type A (CSA) contains glucuronic acid, and 90% of the GalNAc residues are sulfated at the 4-position with 10% at the 6-position. Chondroitin sulfate type C (CSC) contains glucuronic acid, and 90% of the GalNAc residues are sulfated at the 6-position with 10% sulfated at the 4-position. These molecules are fragile due to their high degree of sulfation and are challenging to analyze as a result. This work presents the first evidence that tandem mass spectrometry can be used for the determination of a CS oligosaccharide sequence with respect to the positions of GalNAc sulfation. Using this technique, it is possible to analyze individual components from mixtures, saving much purification effort. Oligosaccharides produced from CSA and CSC are used in this work to demonstrate that CID MS/MS can be used to distinguish positional sulfation isomers. For charge states where charge equals the number of sulfates, abundant odd-numbered Bn and Yn ions are observed. The percent total ion abundances of these ions indicate the position of sulfation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11791576     DOI: 10.1021/ac015577t

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  47 in total

1.  Glycosaminoglycan Analysis by Cryogenic Messenger-Tagging IR Spectroscopy Combined with IMS-MS.

Authors:  Neelam Khanal; Chiara Masellis; Michael Z Kamrath; David E Clemmer; Thomas R Rizzo
Journal:  Anal Chem       Date:  2017-07-07       Impact factor: 6.986

2.  Structural Characterization of Glycosaminoglycan Carbohydrates Using Ultraviolet Photodissociation.

Authors:  Dustin R Klein; Franklin E Leach; I Jonathan Amster; Jennifer S Brodbelt
Journal:  Anal Chem       Date:  2019-04-11       Impact factor: 6.986

3.  Analysis of Sulfate Patterns in Glycosaminoglycan Oligosaccharides by MSn Coupled to Infrared Ion Spectroscopy: the Case of GalNAc4S and GalNAc6S.

Authors:  G Renois-Predelus; B Schindler; I Compagnon
Journal:  J Am Soc Mass Spectrom       Date:  2018-04-26       Impact factor: 3.109

Review 4.  Mass spectrometry and the emerging field of glycomics.

Authors:  Joseph Zaia
Journal:  Chem Biol       Date:  2008-09-22

5.  Tandem mass spectrometric strategies for determination of sulfation positions and uronic acid epimerization in chondroitin sulfate oligosaccharides.

Authors:  Joseph Zaia; Xue-Qing Li; Shiu-Yung Chan; Catherine E Costello
Journal:  J Am Soc Mass Spectrom       Date:  2003-11       Impact factor: 3.109

6.  Electron detachment dissociation of glycosaminoglycan tetrasaccharides.

Authors:  Jeremy J Wolff; I Jonathan Amster; Lianli Chi; Robert J Linhardt
Journal:  J Am Soc Mass Spectrom       Date:  2006-10-30       Impact factor: 3.109

Review 7.  On-line separations combined with MS for analysis of glycosaminoglycans.

Authors:  Joseph Zaia
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

8.  Rapid Differentiation of Chondroitin Sulfate Isomers by Gas-phase Hydrogen-deuterium Exchange.

Authors:  Kimberly M Alonge; Rick Harkewicz; Miklos Guttman
Journal:  Curr Mol Med       Date:  2020       Impact factor: 2.222

9.  Sequence Analysis of Native Oligosaccharides Using Negative ESI Tandem MS.

Authors:  Zhenqing Zhang; Robert J Linhardt
Journal:  Curr Anal Chem       Date:  2009-07-01       Impact factor: 1.892

10.  Structurally informative tandem mass spectrometry of highly sulfated natural and chemoenzymatically synthesized heparin and heparan sulfate glycosaminoglycans.

Authors:  Muchena J Kailemia; Lingyun Li; Yongmei Xu; Jian Liu; Robert J Linhardt; I Jonathan Amster
Journal:  Mol Cell Proteomics       Date:  2013-02-21       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.